abatacept vs oxaprozin
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of abatacept and oxaprozin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Orencia is a medicine that helps to reduce inflammation. It is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and psoriatic arthritis.
Oxaprozin (Daypro) is a nonsteroidal anti-inflammatory drug (NSAID). It helps to reduce pain and swelling.
Orencia treats rheumatoid arthritis in adults. It also treats polyarticular juvenile idiopathic arthritis in patients 2 years and older. Orencia can also treat active psoriatic arthritis in patients 2 years and older. Finally, it can prevent acute graft versus host disease after a stem cell transplant.
This medicine can help with the symptoms of osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis. These conditions can cause pain, swelling, and stiffness in your joints. Oxaprozin can help you feel better by reducing these symptoms.
Orencia works by blocking the activity of certain immune cells called T cells. These T cells can cause inflammation and damage to your joints and other tissues. By blocking T cell activity, Orencia can help reduce inflammation and relieve your symptoms.
Oxaprozin works by reducing substances in the body that cause pain and swelling. It blocks the production of prostaglandins. Prostaglandins contribute to inflammation and pain.
- • Headache
- • Upper respiratory tract infection (like a cold)
- • Runny nose
- • Nausea
- • Constipation
- • Diarrhea
- • Upset stomach
- • Nausea
- • Rash
- Rheumatoid Arthritis 23,596
- Pain 21,295
- Arthralgia 20,151
- Joint Swelling 19,709
- Fatigue 14,200
- Drug Hypersensitivity 386
- Pain 151
- Nausea 134
- Headache 104
- Arthralgia 103
Using Orencia with a TNF antagonist or other biologic medicines can raise your risk of serious infections. Tell your doctor if you have any signs of infection, such as fever, cough, or sore throat. Orencia can also cause allergic reactions, including anaphylaxis. Get medical help right away if you have trouble breathing, swelling, or hives.
NSAIDs like oxaprozin can increase your risk of heart problems like heart attack and stroke. This risk can happen early in treatment and may increase with longer use. You should not take this medicine if you are having heart bypass surgery. NSAIDs also increase the risk of stomach and intestine problems like bleeding and ulcers, which can be fatal. Older adults and people with a history of stomach ulcers are at higher risk.
There is not enough information about Orencia use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
Taking oxaprozin after 20 weeks of pregnancy may harm your baby. Avoid taking this medicine after 30 weeks of pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant.
Also Compare, Nearby Drugs
Compare oxaprozin with
How to Read This abatacept vs oxaprozin Comparison
abatacept is classified in the T-Cell Co-Stimulation Modulator drug class, while oxaprozin sits within the Nonsteroidal Anti-Inflammatory Drug (NSAID) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abatacept has 98,951 submissions while oxaprozin has 878. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for abatacept or oxaprozin.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.